Intervention not reported
Costs or other measures of resource use · women with previous gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cancer occurrence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events
1 finding from 1 review
no estimate extracted
152 participants
Low
Intervention not reported
Pressure symptoms/cosmetic complaints
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Nodule volume reduction ≥ 50%
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Socioeconomic effects
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in all‐cause mortality compared with conventional glycaemic control (moderate certainty).
Cardiovascular mortality · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in cardiovascular mortality compared with conventional glycaemic control (moderate certainty).
1 finding from 1 review
Non‐fatal MI · patients with type 2 diabetes mellitus
Intensive glycaemic control probably leads to lower non‐fatal myocardial infarction compared with conventional glycaemic control (moderate certainty).
1 finding from 1 review
Non‐fatal stroke · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in non‐fatal stroke compared with conventional glycaemic control (moderate certainty).
1 finding from 1 review
Amputation of lower extremity · patients with type 2 diabetes mellitus
Intensive glycaemic control may leads to lower amputation of lower extremity compared with conventional glycaemic control (low certainty).
1 finding from 1 review
End‐stage renal disease · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in end‐stage renal disease compared with conventional glycaemic control (moderate certainty).
1 finding from 1 review
Severe hypoglycaemia · patients with type 2 diabetes mellitus
Intensive glycaemic control leads to higher hypoglycaemia ‐ Severe hypoglycaemia compared with conventional glycaemic control (high certainty).
1 finding from 1 review
Intervention not reported
Diabetes and non‐diabetes related morbidity · peri‐ or postmenopausal women with type 1 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Death from any cause · peri‐ or postmenopausal women with type 1 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects [ · peri‐ or postmenopausal women with type 1 diabetes mellitus
1 finding from 1 review
Intervention not reported
Health‐related quality of life · peri‐ or postmenopausal women with type 1 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Glycaemic control (fructosamine levels) [ · peri‐ or postmenopausal women with type 1 diabetes mellitus
1 finding from 1 review